21 patents currently held
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2029. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Sep 2029
Next term end
19
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Sep 2037 · High confidence
Also notable
Ends Sep 2029 · High confidence
Also notable
Ends Sep 2039 · High confidence
Also notable
Ends Aug 2038 · High confidence
Also notable
Ends Feb 2040 · High confidence
Also notable
Ends Apr 2030 · High confidence
Also notable
Ends Nov 2035 · High confidence
Also notable
Ends Oct 2035 · High confidence
Acid-Alpha Glucosidase Variants and Uses Thereof
US 11,339,406
The most cited patent in this portfolio, cited by 8 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2037.
Functionalized Biochips for Spr-Ms Coupling
US 11,754,561
Granted 2023. Computed term ends 2029.
Antisense Targeting Dynamin 2 and Use for the Treatment of Centronuclear Myopathies and Neuropathies
US 11,499,154
Granted 2022. Computed term ends 2039.
Synthetic Polynucleotides Encoding a Human FKRP Protein
US 11,596,698
Granted 2023. Computed term ends 2038.
Treatment of Glycogen Storage Disease III
US 11,541,131
Granted 2023. Computed term ends 2040.
Polymer Derived from Linear Polyethylenimine for Gene Transfer
US 8,658,150
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2030.
Methods and Tools for Detecting Interactions in Eukaryotic Cells Using Microtubule Structures and Dynamics
US 10,591,486
Granted 2020. Computed term ends 2035.
Novel Aminopyridine Compounds Useful as Inhibitors of Protein Prenylation
US 10,654,838
Granted 2020. Computed term ends 2035.
Formerly held, still cited
Notable
Ends no later than Jun 2032 · Medium confidence
Granted 2016 and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by Université Paris Cité
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for System for Controlling Speed Transition and Thrust Vectorisation in a Multiple-Shaped Nozzle by Secondary Injection (US 11,661,910) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Functionalized Biochips for Spr-Ms Coupling (US 11,754,561) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Sep 17, 2027The maintenance fee for Methods and Tools for Detecting Interactions in Eukaryotic Cells Using Microtubule Structures and Dynamics (US 10,591,486) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 21, 2026
What they patent
The largest of its 19 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
Also on record, not counted in the 21: 4 patents in force now held by others · 4 patents ended · 38 applications pending · 15 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.